4//SEC Filing
Shah Jatin 4
Accession 0001209191-20-007514
CIK 0001503802other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:20 PM ET
Size
8.1 KB
Accession
0001209191-20-007514
Insider Transaction Report
Form 4
Shah Jatin
EVP, Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2020-02-05+22,600→ 22,600 total→ Common Stock (22,600 underlying) - Award
Stock Option (right to buy)
2020-02-05+60,600→ 60,600 totalExercise: $18.00Exp: 2030-02-04→ Common Stock (60,600 underlying)
Footnotes (3)
- [F1]This option was granted on February 5, 2020. The shares underlying this option vest as to 25% of the shares on February 5, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock.
- [F3]The restricted stock units vest in four equal annual installments beginning February 5, 2021, the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following each vesting date, but in any event within 30 days of such date.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001782186
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:20 PM ET
- Size
- 8.1 KB